Bubendorf, Switzerland, Friday, October 21, 2016 - CIS Pharma’s novel solubilization strategy for hydrophobic drugs has successfully reached the proof of concept phase. The Cellophil® Smart Polymer technology platform creates [...]

Bubendorf, Switzerland, Tuesday, September 2, 2015 - CIS Pharma has engaged in a research program to develop a new technology platform that creates water-soluble formulations of highly hydrophobic drugs. The [...]